| Document |
Document Title |
|
WO/2016/120403A1 |
The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to ...
|
|
WO/2016/118932A1 |
The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an im...
|
|
WO/2016/116335A1 |
The present invention describes a process for the selective synthesis of N-Fmoc-doxorubicin-14-O-dicarboxylic acid mono ester derivatives starting from N-Fmoc-doxorubicin using lipase enzymes and bis-acyl donor compounds such as dicarbox...
|
|
WO/2016/115048A1 |
Provided are organic solvent free methods for obtaining compositions comprising one or more rhamnolipids as well as compositions obtainable from said methods.
|
|
WO/2016/110216A1 |
A method for extracting stilbene compounds comprises the following steps: grinding a medicinal material rich in stilbene compounds such as rheum officinale; extracting the medicinal material with a herbal blitzkrieg extractor for one to ...
|
|
WO/2016/109990A1 |
Disclosed is a method for catalytic synthesis of salidroside. The method comprises: enabling total acetyl glucose to react with 4-benzyloxy-phenethyl alcohol under the action of a catalyst to obtain 2-(4-benzyloxyphenyl)ethyl-(2,3,4,6-O-...
|
|
WO/2016/109880A1 |
The invention provides lipid A mimics in which one or both of the sugar residues of a natural lipid A disaccharide backbone has been replaced with an aromatic group. These lipid A mimics may further differ from a natural lipid A molecule...
|
|
WO/2016/112129A1 |
Various embodiments of the present technology provide compositions and methods for a sweetener composition comprising stevia leaf extract, stevia glycosides, and/or Luo Han Guo fruit extract. The sweetener composition provides enhanced t...
|
|
WO/2016/101733A1 |
Provided are a phillygenin glucuronic acid derivative as shown in the formula (I), and a preparation method and antiviral use thereof, etc., wherein R is H, Me, Na+, K+, and so on.
|
|
WO/2016/103530A1 |
Provided are a novel compound having a basic skeleton represented by formula (I) and use of the same as an antioxidant. This compound is derived from 1,5-D-anhydrofructose.
|
|
WO/2016/100689A1 |
Novel steviol glycoside compounds characterized by a first group of four glucopyranose residues attached via the number 13 carbon (C13) of the steviol moiety and a second group of two or three glucopyranose residues attached via the numb...
|
|
WO/2016/098048A1 |
The invention relates to a bactericidal or bacteriostatic composition comprising an acetal or a long-chain alkyl hexitane ether, preferably sorbitan, arlitan or mannitan, the user thereof in the treatment or prevention of infections invo...
|
|
WO/2016/098046A1 |
The invention relates to a bactericidal or bacteriostatic composition comprising a mixture of isomers of monosaccharide alkyl monoacetals or monoethers, the use thereof in the treatment or prevention of infections involving Gram-positive...
|
|
WO/2016/090460A1 |
A Stevia rebaudiana variety characterized by high levels of Rebaudioside C (RC) is disclosed. The variety comprises from about 3-8% by weight RC in the leaf (leaf content) and from about 10-13% total steviol glycosides content (TSG) in t...
|
|
WO/2016/091399A1 |
The present invention relates to synthetic saccharides of general formula (I) that are related to Streptococcus pneumoniae serotype 4 capsular polysaccharide and conjugates thereof. Said conjugate and a pharmaceutical composition contain...
|
|
WO/2016/092030A1 |
A sugar surfactant of formula (I), where R1 is H or an alkyl group comprising 1 to 3 carbon atoms and R2 is a polyhydroxy-hydrocarbyl group comprising a straight hydrocarbyl chain to which at least three hydroxyl groups are directly bond...
|
|
WO/2016/089872A1 |
Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of t...
|
|
WO/2016/088076A1 |
The present invention relates to a process for obtaining a mixture of C4-C8 and C9-C18 alkyl monoethers of a saccharide, comprising: a) a first step of acetalization or trans-acetalization of a saccharide or a mixture of saccharides by...
|
|
WO/2016/086108A1 |
Novel diterpene glycosides and methods for purifying the same are provided herein. In addition, compositions comprising the novel diterpene glycosides, as well as methods of using the diterpene glycosides are provided. Novel diterpene gl...
|
|
WO/2016/086097A1 |
A novel diterpene glycoside and methods for preparing and purifying the same are provided herein. In addition, compositions comprising the novel diterpene glycoside, as well as methods of using the diterpene glycoside are provided.
|
|
WO/2016/080850A1 |
Water dispersible, multivalent ligand-lipid constructs that spontaneously and stably incorporate into membranes are disclosed.
|
|
WO/2016/077126A1 |
The present invention relates to certain SGLT-2 inhibitors, such as ertugliflozin or a co-crystal or a pharmaceutically acceptable salt thereof, for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellit...
|
|
WO/2016/070740A1 |
The present invention discloses a class of a compound shown by general formula (I), a pharmaceutically acceptable salt thereof, an easily hydrolyzed prodrug ester or an isomer thereof, a pharmaceutical composition containing this class o...
|
|
WO/2016/070849A1 |
Provided in the present invention are a class of Lincomycin biosynthetic intermediates and a preparation method and use thereof. Specifically provided are Lincomycin biosynthetic intermediates obtained from the genetic modification of a ...
|
|
WO/2016/069826A1 |
Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae vims infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula (IV): The compounds, compositions, and methods pro...
|
|
WO/2016/069825A1 |
Provided are methods of preparing compounds and pharmaceutical compositions for treating Filoviridae virus infections the compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola vir...
|
|
WO/2016/069827A1 |
Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula (I), wherein the position of the nucleoside sugar...
|
|
WO/2016/063262A1 |
The invention relates to a mixture of human milk oligosaccharides that consists essentially of: a)a component A which is 3-FL or DFL, a component B which is LNT, LNnT, LNFP-I or 2'-FL, a component C, which is -LNFP-II when component B is...
|
|
WO/2016/058071A1 |
The present invention relates to the method for extracting and isolating active substances from umbu pulp (Spondias tuberosa Arr. Camara). Besides high acetylcholinesterase inhibitory activity, the active substances also exhibit powerful...
|
|
WO/2016/055601A1 |
This invention generally relates to the field of phosphoramidite derivatives. In particular, the invention relates to N-Acetylgalactosamine phosphoramidite molecules and to conjugates of nucleic acid molecules with N-Acetylgalactosamine ...
|
|
WO/2016/054568A1 |
The present application provides processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054534A1 |
Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside ...
|
|
WO/2016/054505A1 |
The present application provides processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054539A1 |
Methyl alpha-L-rhamnopyranosides are selectively alkylated in the 3-position with catalytic amounts of dialkyltin compounds in the presence of halide additives and base.
|
|
WO/2016/054564A1 |
The present application provides processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054573A1 |
The present application describes processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054544A1 |
Disclosed are steviol glycosides referred to as rebaudioslde V and rebaudioslde W. Also disclosed are methods for producing rebaudioslde M (Reb M), rebausoside G (Reb G)', rebaudioslde KA (Reb KA), rebaudioslde V (Reb V) and rebaudioslde...
|
|
WO/2016/051187A1 |
There are provided compounds of formula I, wherein R1A to R1E, R2 to R4, R5a, L and X1 to X3 have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: th...
|
|
WO/2016/054281A2 |
A method for the purification of idraparinux sodium includes: passing a solution including a crude idraparinux sodium through a column including a sodium ion exchange resin to obtain a first mixture; passing a solution including the firs...
|
|
WO/2016/054540A1 |
Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside ...
|
|
WO/2016/052488A1 |
[Problem] To provide a chelate compound that has a high safety and is applicable to various uses. [Solution] A chelate compound wherein a chelate-forming moiety is attached to a base compound having an amino group and at least a part of ...
|
|
WO/2016/047428A1 |
[Problem] To provide a cyclic hemiacetal compound production method that is performed under mild conditions easily and at a high yield and that is superior in stereoselectivity and enables mass production. [Solution] Provided is a produc...
|
|
WO/2016/046420A1 |
The present invention relates to synthetic saccharides of general formula (I) that are related to Streptococcus pneumoniae serotype 8 capsular polysaccharide, conjugates thereof and the use of said saccharides and conjugates for raising ...
|
|
WO/2016/049315A1 |
Stevia compositions are prepared from Stevia rebaudiana Bertoni extracts. The compositions are able to provide a superior taste profile and can be used as sweeteners, sweetness enhancers, flavors, flavor enhancers in foods, beverages, co...
|
|
WO/2016/046419A1 |
The present invention relates to novel immunostimulatory molecules which are derived from the intestinal protozoan Entamoeba histolytica.The compounds have been found to be useful for enhancing and/or inducing an immune response in a sub...
|
|
WO/2016/041698A1 |
Mixtures comprising a mixture of compounds (A), said mixture comprising a mixture of compounds according to the general formula (I) wherein R1 is C1 -C 4 -alkyl, linear or branched, or hydrogen, R 2 is -CH 2 CH2 R1, each G 1 is glucose o...
|
|
WO/2016/043501A1 |
A method for preparing an anhydrosugar alcohol, according to the present invention, can increase the yield of the anhydrosugar alcohol even without adding a catalyst or with only a small amount of catalyst, by controlling the reaction te...
|
|
WO/2016/038205A1 |
The invention relates to fluorescent conjugates of formula (I) (I) where CG is a carbohydrate compound selected from the monosaccharide residues, the oligosaccharides and the polyoligosaccharides comprising at least one monosaccharide re...
|
|
WO/2016/038192A1 |
The present invention relates to a method for preparing 2'-O-fucosyllactose, the 2'-O-fucosyllactose obtainable by this method and the use thereof. The method comprises reacting the persilylated, protected fucose derivatives of the formu...
|
|
WO/2016/040369A2 |
Glycosphingolipids (GSLs) compositions and methods for iNKT-independent induction of chemokines are disclosed.
|
